Literature DB >> 23921420

Relapse patterns in pediatric embryonal central nervous system tumors.

Sébastien Perreault1, Robert M Lober, Anne-Sophie Carret, Guohua Zhang, Linda Hershon, Jean-Claude Décarie, Kristen Yeom, Hannes Vogel, Paul G Fisher, Sonia Partap.   

Abstract

Embryonal tumors of the central nervous system (CNS) share histological features and were therefore initially grouped as primitive neuroectodermal tumors (PNET) and treated similarly. We sought to determine the relapse patterns of specific embryonal CNS tumors. We conducted a historical cohort study of children diagnosed with CNS embryonal tumors from January 2000 to December 2011 in two pediatric neuro-oncology centers. Patients of 21 years of age or younger at time of presentation with a diagnosis of medulloblastoma, supratentorial PNET, pineoblastoma or atypical teratoid/rhabdoid tumor (ATRT) and at least one surveillance MRI were included. A total of 133 patients met inclusion criteria and 49 (37 %) patients relapsed during the observation period. The majority (79 %) of sPNET relapses were local, whereas all (100 %) PB relapses were associated with diffuse leptomeningeal disease. Relapse patterns for MB were more diverse with local recurrence in 27 %, distant recurrence in 35 % and diffuse leptomeningeal disease in 38 %. The frequency of relapses involving the spine differed (p < 0.001) between tumor types (MB 28/55 [51 %], sPNET 3/33 [9 %], ATRT 3/7 [43 %] and PB 12/12 [100 %]). No sPNET patients had isolated spinal relapse (0/14). Embryonal tumors were found to have divergent patterns of recurrence. While medulloblastoma has variable relapse presentations, sPNET relapses locally and pineoblastoma recurs with diffuse leptomeningeal disease involving the spine. These results point toward possibly new upfront treatment stratification among embryonal tumors in accordance with relapse pattern.

Entities:  

Mesh:

Year:  2013        PMID: 23921420     DOI: 10.1007/s11060-013-1213-4

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  24 in total

Review 1.  Impact of radiation technique upon the outcome of treatment for medulloblastoma.

Authors:  E C Halperin
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-08-01       Impact factor: 7.038

2.  Functional genomics identifies drivers of medulloblastoma dissemination.

Authors:  Michael Mumert; Adrian Dubuc; Xiaochong Wu; Paul A Northcott; Steven S Chin; Carolyn A Pedone; Michael D Taylor; Daniel W Fults
Journal:  Cancer Res       Date:  2012-08-08       Impact factor: 12.701

3.  Role of radiotherapy in the treatment of supratentorial primitive neuroectodermal tumors in childhood: results of the prospective German brain tumor trials HIT 88/89 and 91.

Authors:  Beate Timmermann; Rolf-Dieter Kortmann; Joachim Kühl; Christoph Meisner; Karin Dieckmann; Torsten Pietsch; Michael Bamberg
Journal:  J Clin Oncol       Date:  2002-02-01       Impact factor: 44.544

4.  Central nervous system atypical teratoid rhabdoid tumours: the Canadian Paediatric Brain Tumour Consortium experience.

Authors:  L Lafay-Cousin; C Hawkins; A S Carret; D Johnston; S Zelcer; B Wilson; N Jabado; K Scheinemann; D Eisenstat; C Fryer; A Fleming; C Mpofu; V Larouche; D Strother; E Bouffet; A Huang
Journal:  Eur J Cancer       Date:  2011-10-22       Impact factor: 9.162

5.  Recurrence in childhood medulloblastoma.

Authors:  Monika Warmuth-Metz; Sophia Blashofer; André O von Bueren; Katja von Hoff; Brigitte Bison; Fabian Pohl; Rolf-Dieter Kortmann; Torsten Pietsch; Stefan Rutkowski
Journal:  J Neurooncol       Date:  2010-11-11       Impact factor: 4.130

6.  Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy.

Authors:  Carsten Friedrich; André O von Bueren; Katja von Hoff; Nicolas U Gerber; Holger Ottensmeier; Frank Deinlein; Martin Benesch; Robert Kwiecien; Torsten Pietsch; Monika Warmuth-Metz; Andreas Faldum; Joachim Kuehl; Rolf D Kortmann; Stefan Rutkowski
Journal:  Neuro Oncol       Date:  2012-12-07       Impact factor: 12.300

7.  Patterns of failure in supratentorial primitive neuroectodermal tumors treated in Children's Cancer Group Study 921, a phase III combined modality study.

Authors:  Theodore S Hong; Minesh P Mehta; James M Boyett; Bernadine Donahue; Lucy B Rorke; Michelle S Yao; Paul M Zeltzer
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-09-01       Impact factor: 7.038

8.  Survival and prognostic factors following radiation and/or chemotherapy for primitive neuroectodermal tumors of the pineal region in infants and children: a report of the Childrens Cancer Group.

Authors:  R I Jakacki; P M Zeltzer; J M Boyett; A L Albright; J C Allen; J R Geyer; L B Rorke; P Stanley; K R Stevens; J Wisoff
Journal:  J Clin Oncol       Date:  1995-06       Impact factor: 44.544

9.  Childhood atypical teratoid rhabdoid tumor of the central nervous system: a meta-analysis of observational studies.

Authors:  Uma H Athale; JoAnn Duckworth; Isaac Odame; Ronald Barr
Journal:  J Pediatr Hematol Oncol       Date:  2009-09       Impact factor: 1.289

10.  Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor.

Authors:  Susan N Chi; Mary Ann Zimmerman; Xiaopan Yao; Kenneth J Cohen; Peter Burger; Jaclyn A Biegel; Lucy B Rorke-Adams; Michael J Fisher; Anna Janss; Claire Mazewski; Stewart Goldman; Peter E Manley; Daniel C Bowers; Anne Bendel; Joshua Rubin; Christopher D Turner; Karen J Marcus; Liliana Goumnerova; Nicole J Ullrich; Mark W Kieran
Journal:  J Clin Oncol       Date:  2008-12-08       Impact factor: 44.544

View more
  9 in total

1.  Long-term survival following additive radiotherapy in patients with atypical teratoid rhabdoid tumors.

Authors:  Khaled Elsayad; Jan Kriz; Laith Samhouri; Uwe Haverkamp; Ronald Straeter; Walter Stummer; Hans Theodor Eich
Journal:  Strahlenther Onkol       Date:  2016-06-07       Impact factor: 3.621

2.  Hippocampal sparing radiotherapy for pediatric medulloblastoma: impact of treatment margins and treatment technique.

Authors:  N Patrik Brodin; Per Munck af Rosenschöld; Malin Blomstrand; Anne Kiil-Berthlesen; Christian Hollensen; Ivan R Vogelius; Birgitta Lannering; Søren M Bentzen; Thomas Björk-Eriksson
Journal:  Neuro Oncol       Date:  2013-12-09       Impact factor: 12.300

Review 3.  Medulloblastoma.

Authors:  Nathan E Millard; Kevin C De Braganca
Journal:  J Child Neurol       Date:  2015-09-02       Impact factor: 1.987

Review 4.  Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape.

Authors:  Amar Gajjar; Daniel C Bowers; Matthias A Karajannis; Sarah Leary; Hendrik Witt; Nicholas G Gottardo
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

5.  Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors.

Authors:  Joshua D Bernstock; Asim K Bag; John Fiveash; Kara Kachurak; Galal Elsayed; Gustavo Chagoya; Florian Gessler; Pablo A Valdes; Avi Madan-Swain; Richard Whitley; James M Markert; G Yancey Gillespie; James M Johnston; Gregory K Friedman
Journal:  Hum Gene Ther       Date:  2020-08-17       Impact factor: 5.695

6.  Highly Conformal Craniospinal Radiotherapy Techniques Can Underdose the Cranial Clinical Target Volume if Leptomeningeal Extension through Skull Base Exit Foramina is not Contoured.

Authors:  D J Noble; T Ajithkumar; J Lambert; I Gleeson; M V Williams; S J Jefferies
Journal:  Clin Oncol (R Coll Radiol)       Date:  2017-03-18       Impact factor: 4.126

7.  Added value of diffusion weighted imaging in pediatric central nervous system embryonal tumors surveillance.

Authors:  Giovanni Morana; Cesar Augusto Alves; Domenico Tortora; Mariasavina Severino; Paolo Nozza; Armando Cama; Marcello Ravegnani; Gabriella D'Apolito; Alessandro Raso; Claudia Milanaccio; Claudia da Costa Leite; Maria Luisa Garrè; Andrea Rossi
Journal:  Oncotarget       Date:  2017-07-25

Review 8.  Atypical teratoid/rhabdoid tumors: challenges and search for solutions.

Authors:  Ahitagni Biswas; Lakhan Kashyap; Aanchal Kakkar; Chitra Sarkar; Pramod Kumar Julka
Journal:  Cancer Manag Res       Date:  2016-09-16       Impact factor: 3.989

Review 9.  Medulloblastoma in children and adolescents: a systematic review of contemporary phase I and II clinical trials and biology update.

Authors:  Francisco Bautista; Victoria Fioravantti; Teresa de Rojas; Fernando Carceller; Luis Madero; Alvaro Lassaletta; Lucas Moreno
Journal:  Cancer Med       Date:  2017-10-04       Impact factor: 4.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.